Risk factors for and incidence of acute hepatitis C after the achievement of blood supply safety in Italy: Results from the national surveillance system
Authors:
- Enea SpadaESEnea Spada
- Maria Elena TostiMTMaria Elena Tosti
- on behalf of SEIEVA collaborating groupOGon behalf of SEIEVA collaborating group
- 28 December 2012
- journal article
- Published by Wiley in Journal of Medical Virology
- Vol. 85 (3) , 433-440
Abstract
Surveillance systems for acute hepatitis C allow monitoring of disease incidence trends and transmission patterns. This study aimed to describe the epidemiological profile of reported cases of symptomatic acute hepatitis C in Italy after the achievement of blood supply safety. The incidence of symptomatic acute hepatitis C since 1991 was estimated. Risk factors for acute hepatitis C were analyzed for the period 2003–2010 through a case–control study within a population‐based surveillance for acute viral hepatitis. From 1991 to 2010, the incidence decreased from 2 to 0.2 per 100,000, with a more evident decrease among persons aged 15–24 years. During 2003–2010, 1,053 cases were reported. Intravenous drug use (adjusted odds ratio [adjOR], 30.5; 95% confidence interval [CI], 18.9–49.1), cohabitation or sexual partnership with an hepatitis C virus (HCV) carrier (adjOR, 11.2; 95% CI, 6.6–19.2), nosocomial exposure (adjOR, 6.6; 95% CI, 4.6–9.4); unsafe sexual practices (adjOR, 3.1; 95% CI, 1.9–5.2), and cosmetic treatments with percutaneous exposure (adjOR, 1.7; 95% CI, 1.2–2.4) were independently associated with acute hepatitis C. Population attributable risk estimates indicated nosocomial exposure (39.6%) and intravenous drug use (30.5%) as responsible for most cases. In conclusion, the incidence of symptomatic acute hepatitis C is declining in Italy. Currently, the most important risk factors are: having an HCV‐positive household or sexual partner, unsafe sexual practices, cosmetic percutaneous treatments, intravenous drug use, and nosocomial exposure; the latter two factors are responsible for most cases. Effective prevention programs for intravenous drug users and strict adherence to universal precautions in healthcare settings are needed. J. Med. Virol. 85:433–440, 2013.Keywords
This publication has 28 references indexed in Scilit:
- Intrafamilial transmission of hepatitis C virus in Italy: a systematic reviewJournal of Epidemiology and Community Health, 2009
- Epidemiology of HCV Infection in the General Population: A Survey in a Southern Italian TownAmerican Journal of Gastroenterology, 2009
- Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: A cross-sectional studyScandinavian Journal of Infectious Diseases, 2009
- Hepatitis C Virus Acquisition among Injecting Drug Users: A Cohort Analysis of a National Repeated Cross-sectional Survey of Needle and Syringe Program Attendees in Australia, 1995–2004Journal of Urban Health, 2008
- Changing Epidemiology of HCV and HBV Infections in Northern ItalyJournal of Clinical Gastroenterology, 2008
- The changing epidemiology of hepatitis C virus infection in EuropeJournal of Hepatology, 2008
- An Incident Case–Control Study of Modes of Hepatitis C Virus Transmission in FranceAnnals of Epidemiology, 2007
- Nosocomial transmission of HCV in the liver unit of a tertiary care centerHepatology, 2004
- The challenge of hepatitis C surveillance in EuropeEurosurveillance, 2003
- Spread of hepatitis C virus among sexual partners of HCVAb positive intravenous drug usersJournal of Infection, 1994